{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:16:57Z","timestamp":1793452617466,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Heart failure (HF) affects more than 6 million adults in the US and more than 64 million adults worldwide, with 50% prevalence of depression. Patients and clinicians lack information on which interventions are more effective for depression in HF.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare the effectiveness of behavioral activation psychotherapy (BA) vs antidepressant medication management (MEDS) on patient-centered outcomes inpatients with HF and depression.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This pragmatic randomized comparative effectiveness trial was conducted from 2018 to 2022, including 1-year follow-up, at a not-for-profit academic health system serving more than 2 million people from diverse demographic, socioeconomic, cultural, and geographic backgrounds. Participant included inpatients and outpatients diagnosed with HF and depression, and data were analyzed as intention-to-treat. Data were analyzed from 2022 to 2023.<\/jats:p><\/jats:sec>Interventions<\/jats:title>BA is an evidence-based manualized treatment for depression, promoting engagement in personalized pleasurable activities selected by patients. MEDS involves the use of an evidence-based collaborative care model with care managers providing coordination with patients, psychiatrists, and primary care physicians to only administer medications.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was depressive symptom severity at 6 months, measured using the Patient Health Questionnaire 9-Item (PHQ-9). Secondary outcomes included physical and mental health-related quality of life (HRQOL), measured using the Short-Form 12-Item version 2 (SF-12); heart failure-specific HRQOL, measured using the Kansas City Cardiomyopathy Questionnaire; caregiver burden, measured with the Caregiver Burden Questionnaire for Heart Failure; emergency department visits; readmissions; days hospitalized; and mortality at 3, 6, and 12 months.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 416 patients (mean [SD] age, 60.71 [15.61] years; 243 [58.41%] male) were enrolled, with 208 patients randomized to BA and 208 patients randomized to MEDS. At baseline, mean (SD) PHQ-9 scores were 14.54 (3.45) in the BA group and 14.31 (3.60) in the MEDS group; both BA and MEDS recipients experienced nearly 50% reduction in depressive symptoms at 3, 6, and 12 months (eg, mean [SD] score at 12 months: BA, 7.62 (5.73); P<\/jats:italic>\u2009&amp;lt;\u2009.001; MEDS, 7.98 (6.06); P<\/jats:italic>\u2009&amp;lt;\u2009.001; between-group P<\/jats:italic>\u2009=\u2009.55). There was no statistically significant difference between BA and MEDS in the primary outcome of PHQ-9 at 6 months (mean [SD] score, 7.53 [5.74] vs 8.09 [6.06]; P<\/jats:italic>\u2009=\u2009.88). BA recipients, compared with MEDS recipients, experienced small improvement in physical HRQOL at 6 months (mean [SD] SF-12 physical score: 38.82 [11.09] vs 37.12 [10.99]; P<\/jats:italic>\u2009=\u2009.04), had fewer ED visits (3 months: 38% [95% CI, 14%-55%] reduction; P<\/jats:italic>\u2009=\u2009.005; 6 months: 30% [95% CI, 14%-40%] reduction; P<\/jats:italic>\u2009=\u2009.008; 12 months: 27% [95% CI, 15%-38%] reduction; P<\/jats:italic>\u2009=\u2009.001), and spent fewer days hospitalized (3 months: 17% [95% CI, 8%-25%] reduction; P<\/jats:italic>\u2009=\u2009.002; 6 months: 19% [95% CI, 13%-25%] reduction; P<\/jats:italic>\u2009=\u2009.005; 12 months: 36% [95% CI, 32%-40%] reduction; P<\/jats:italic>\u2009=\u2009.001).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this comparative effectiveness trial of BA and MEDS in patients with HF experiencing depression, both treatments significantly reduced depressive symptoms by nearly 50% with no statistically significant differences between treatments. BA recipients experienced better physical HRQOL, fewer ED visits, and fewer days hospitalized. The study findings suggested that patients with HF could be given the choice between BA or MEDS to ameliorate depression.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03688100<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.52094","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T17:52:17Z","timestamp":1705513937000},"page":"e2352094","source":"Crossref","is-referenced-by-count":16,"title":["Comparative Effectiveness of Psychotherapy vs Antidepressants for Depression in Heart Failure"],"prefix":"10.1001","volume":"7","author":[{"given":"Waguih William","family":"IsHak","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Korouri","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio A.","family":"Diniz","sequence":"additional","affiliation":[{"name":"Biostatistics Research Center, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mirocha","sequence":"additional","affiliation":[{"name":"Biostatistics Research Center, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hedrick","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Chernoff","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne T.","family":"Black","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Health System, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Nursing Research, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Vanle","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarneem","family":"Darwish","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Messineo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Collier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Pasini","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleab K.","family":"Tessema","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Harold","sequence":"additional","affiliation":[{"name":"Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Ong","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan","family":"Spiegel","sequence":"additional","affiliation":[{"name":"Division of Health Services Research, Department of Medicine, Cedars-Sinai Health System, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Wells","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Danovitch","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"zoi231525r1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/amj","article-title":"Global epidemiology and future trends of heart failure.","volume":"5","author":"Lippi","year":"2020","journal-title":"AME Med J"},{"issue":"1","key":"zoi231525r2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13033-021-00467-x","article-title":"The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure.","volume":"15","author":"Tsabedze","year":"2021","journal-title":"Int J Ment Health Syst"},{"issue":"3","key":"zoi231525r3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/chf.2003.9.issue-3","article-title":"Depression and congestive heart failure.","volume":"9","author":"Guck","year":"2003","journal-title":"Congest Heart Fail"},{"issue":"4","key":"zoi231525r4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jacc.2010.09.031","article-title":"Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure.","volume":"57","author":"Sherwood","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"zoi231525r5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cardfail.2004.01.011","article-title":"Depression and health status in patients with advanced heart failure: a prospective study in tertiary care.","volume":"10","author":"Sullivan","year":"2004","journal-title":"J Card Fail"},{"issue":"3","key":"zoi231525r6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCHEARTFAILURE.112.000118","article-title":"Depression, healthcare utilization, and death in heart failure: a community study.","volume":"6","author":"Moraska","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"1","key":"zoi231525r7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/SPC.0000000000000182","article-title":"An integrated review of interventions to improve psychological outcomes in caregivers of patients with heart failure.","volume":"10","author":"Evangelista","year":"2016","journal-title":"Curr Opin Support Palliat Care"},{"issue":"10","key":"zoi231525r8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cardfail.2007.07.008","article-title":"Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice.","volume":"13","author":"M\u00fcller-Tasch","year":"2007","journal-title":"J Card Fail"},{"issue":"1","key":"zoi231525r9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0735-1097(01)01334-1","article-title":"Depressive symptoms and risk of functional decline and death in patients with heart failure.","volume":"38","author":"Vaccarino","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"zoi231525r10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ijcard.2012.03.143","article-title":"Depression, antidepressants, and long-term mortality in heart failure.","volume":"167","author":"Diez-Quevedo","year":"2013","journal-title":"Int J Cardiol"},{"issue":"17","key":"zoi231525r11","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","article-title":"Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"issue":"4-6","key":"zoi231525r12","first-page":"27","article-title":"Depression in heart failure: a systematic review.","volume":"17","author":"Ishak","year":"2020","journal-title":"Innov Clin Neurosci"},{"issue":"6","key":"zoi231525r13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10741-017-9640-5","article-title":"Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis.","volume":"22","author":"Jeyanantham","year":"2017","journal-title":"Heart Fail Rev"},{"issue":"3","key":"zoi231525r14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cpr.2006.11.001","article-title":"Behavioral activation treatments of depression: a meta-analysis.","volume":"27","author":"Cuijpers","year":"2007","journal-title":"Clin Psychol Rev"},{"issue":"10047","key":"zoi231525r15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(16)31140-0","article-title":"Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.","volume":"388","author":"Richards","year":"2016","journal-title":"Lancet"},{"key":"zoi231525r16","article-title":"A single cognitive behavioral therapy session improves short-term depressive symptoms in hospitalized patients with heart failure.","volume":"130","author":"Dekker","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"zoi231525r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100100","article-title":"Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis.","volume":"9","author":"Ekers","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"zoi231525r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244453","article-title":"Personalized treatments for depressive symptoms in patients with advanced heart failure: a pragmatic randomized controlled trial.","volume":"16","author":"IsHak","year":"2021","journal-title":"PLoS One"},{"key":"zoi231525r19","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose.","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"zoi231525r20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0145445510390929","article-title":"Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual.","volume":"35","author":"Lejuez","year":"2011","journal-title":"Behav Modif"},{"issue":"22","key":"zoi231525r21","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1001\/jama.288.22.2836","article-title":"Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.","volume":"288","author":"Un\u00fctzer","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"zoi231525r22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jval.2015.12.015","article-title":"Cost-effectiveness of a collaborative care depression and anxiety treatment program in patients with acute cardiac illness.","volume":"19","author":"Celano","year":"2016","journal-title":"Value Health"},{"issue":"19","key":"zoi231525r23","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1001\/jama.2009.1670","article-title":"Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial.","volume":"302","author":"Rollman","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"zoi231525r24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"5","key":"zoi231525r26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"zoi231525r27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1477-7525-11-84","article-title":"The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity.","volume":"11","author":"Humphrey","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"zoi231525r28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1541-0420.2008.01177.x","article-title":"Using regression models to analyze randomized trials: asymptotically valid hypothesis tests despite incorrectly specified models.","volume":"65","author":"Rosenblum","year":"2009","journal-title":"Biometrics"},{"issue":"13","key":"zoi231525r29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/1097-0258(20000715)19:13<1793::AID-SIM482>3.0.CO;2-Q","article-title":"Modelling covariance structure in the analysis of repeated measures data.","volume":"19","author":"Littell","year":"2000","journal-title":"Stat Med"},{"issue":"3","key":"zoi231525r30","first-page":"1","article-title":"MICE: multivariate imputation by chained equations in R.","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Soft"},{"issue":"1","key":"zoi231525r31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.2044-8317.2011.02031.x","article-title":"The analysis of zero-inflated count data: beyond zero-inflated Poisson regression.","volume":"65","author":"Loeys","year":"2012","journal-title":"Br J Math Stat Psychol"},{"issue":"1","key":"zoi231525r33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12955-020-01312-4","article-title":"Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain.","volume":"18","author":"Rieckmann","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"zoi231525r34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2016.07.057","article-title":"Depression in heart failure: can PHQ-9 help?","volume":"221","author":"Bhatt","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"zoi231525r35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.","volume":"297","author":"Lesp\u00e9rance","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"zoi231525r36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2021.4978","article-title":"Efficacy of blended collaborative care for patients with heart failure and comorbid depression: a randomized clinical trial.","volume":"181","author":"Rollman","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi231525r37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12872-023-03500-8","article-title":"Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure.","volume":"23","author":"Veskovic","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"zoi231525r38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamainternmed.2017.8667","article-title":"Effect of a collaborative care intervention vs usual care on health status of patients with chronic heart failure: the CASA randomized clinical trial.","volume":"178","author":"Bekelman","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi231525r39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1536\/ihj.18-408","article-title":"Efficacy of cognitive behavioral therapy for heart failure.","volume":"60","author":"Peng","year":"2019","journal-title":"Int Heart J"},{"issue":"8","key":"zoi231525r40","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.5556","article-title":"The effect of guided web-based cognitive behavioral therapy on patients with depressive symptoms and heart failure: a pilot randomized controlled trial.","volume":"18","author":"Lundgren","year":"2016","journal-title":"J Med Internet Res"},{"key":"zoi231525r41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.apnr.2016.01.002","article-title":"The effectiveness of a nurse-led cognitive-behavioral therapy on the quality of life, self-esteem and mood among Filipino patients living with heart failure: a randomized controlled trial.","volume":"31","author":"Cajanding","year":"2016","journal-title":"Appl Nurs Res"},{"key":"zoi231525r42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpsychires.2018.10.007","article-title":"Comparison of treatment options for depression in heart failure: a network meta-analysis.","volume":"108","author":"Das","year":"2019","journal-title":"J Psychiatr Res"},{"issue":"3","key":"zoi231525r43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00045391-200007030-00008","article-title":"Recognition and management of depression in primary care: a focus on the elderly: a pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.","volume":"7","author":"Barkin","year":"2000","journal-title":"Am J Ther"},{"issue":"2","key":"zoi231525r44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7326\/M22-1900","article-title":"Values and preferences of patients with depressive disorders regarding pharmacologic and nonpharmacologic treatments: a rapid review.","volume":"176","author":"Affengruber","year":"2023","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi231525r45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamacardio.2019.4987","article-title":"Patient perceptions and familiarity with medical therapy for heart failure.","volume":"5","author":"Samsky","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"6","key":"zoi231525r46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.pec.2015.02.008","article-title":"A patient-centered perspective of treating depressive symptoms in chronic heart failure: what do patients prefer?","volume":"98","author":"Lossnitzer","year":"2015","journal-title":"Patient Educ Couns"},{"issue":"9","key":"zoi231525r47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0735-1097(22)01253-0","article-title":"Rates of psychotherapy referral among heart failure patients with depression using a national database.","volume":"79","author":"Latif","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi231525r48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women\u2019s participation in cardiovascular clinical trials from 2010 to 2017.","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"issue":"17","key":"zoi231525r49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021108","article-title":"Recruitment of Black adults into cardiovascular disease trials.","volume":"10","author":"Prasanna","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"zoi231525r50","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.3390\/jcm11102790","article-title":"Clinical support through telemedicine in heart failure outpatients during the COVID-19 pandemic period: results of a 12-months follow up.","volume":"11","author":"Severino","year":"2022","journal-title":"J Clin Med"},{"issue":"10","key":"zoi231525r51","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMp2110679","article-title":"COVID-induced changes in health care delivery\u2014can they last?","volume":"385","author":"Werner","year":"2021","journal-title":"N Engl J Med"},{"key":"zoi231525r25","volume-title":"How to Score Version 2 of the SF-12 HEALTH Survey","author":"Ware","year":"2002"},{"key":"zoi231525r32","volume-title":"User\u2019s Manual for the SF-12v2 Health Survey","author":"Ware","year":"2009","edition":"2nd ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2814018\/ishak_2024_oi_231525_1704751054.63141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T17:52:31Z","timestamp":1705513951000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2814018"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.52094","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]}}}